Goat Thyroid Extract (Capra aegagrus hircus)

Goat thyroid extract is a desiccated glandular supplement derived from Capra aegagrus hircus thyroid tissue, containing naturally occurring thyroxine (T4) and triiodothyronine (T3) in their biological ratios. It is proposed to support thyroid hormone metabolism by supplying exogenous thyroid hormones and glandular cofactors, though no human clinical trials have specifically validated its efficacy.

Origin & History

Goat thyroid extract is derived from the thyroid glands of goats (Capra aegagrus hircus), a domestic ruminant species. It belongs to the class of desiccated thyroid extracts (DTE), which are animal-derived supplements processed by drying and powdering thyroid tissue, similar to porcine-derived versions used historically for hypothyroidism.

Historical & Cultural Context

No evidence of goat thyroid extract in traditional medicine systems was found. While porcine natural desiccated thyroid (NDT) was widely used globally for hypothyroidism before synthetics, goat sources lack historical documentation.

Health Benefits

• No human clinical evidence exists for goat thyroid extract specifically - all health benefit claims lack clinical validation
• Porcine DTE showed modest weight loss (4 lbs) in 48.6% of patients who preferred it over levothyroxine (moderate evidence quality, n=70 RCT)
• May provide natural T3 and T4 hormones similar to other desiccated thyroid products (theoretical benefit, no goat-specific evidence)
• Some patients subjectively preferred porcine DTE for symptom relief versus synthetic hormones (low evidence quality)
• No quality of life improvements demonstrated versus standard thyroid medications in systematic reviews (2 RCTs, 9 non-randomized studies)

How It Works

Goat thyroid extract contains preformed triiodothyronine (T3) and thyroxine (T4), which bind to nuclear thyroid hormone receptors (TRα and TRβ) to regulate gene transcription governing metabolism, thermogenesis, and protein synthesis. T4 is peripherally converted to the more bioactive T3 via iodothyronine deiodinase enzymes (DIO1, DIO2), influencing basal metabolic rate, mitochondrial oxidative phosphorylation, and cardiac output. The glandular matrix may also supply iodine, thyroglobulin peptides, and trace cofactors that support endogenous thyroid hormone synthesis via the thyroid peroxidase (TPO) pathway.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for goat thyroid extract specifically. Evidence is limited to porcine DTE studies: one RCT (n=70, PMID: 23539727) found no quality-of-life improvement versus levothyroxine, and a 2024 systematic review (PMID: 38526391) reported no benefits versus standard treatments. Goat studies focus only on animal models of hypothyroidism using propylthiouracil (n=16 goat kids).

Clinical Summary

No published randomized controlled trials exist specifically examining goat thyroid extract in humans, making direct evidence for its efficacy absent. Evidence is partially extrapolated from research on porcine desiccated thyroid extract (DTE), where a 70-patient RCT found that 48.6% of participants preferred DTE over levothyroxine monotherapy, with DTE users experiencing approximately 4 lbs greater weight loss. A 2013 crossover RCT (n=70, Hoang et al., Journal of Clinical Endocrinology & Metabolism) confirmed non-inferiority of porcine DTE to levothyroxine on TSH normalization, though extrapolating these findings to caprine-sourced extract is scientifically unvalidated. Overall evidence quality for goat thyroid extract specifically remains very low, and regulatory bodies such as the FDA do not approve it as a thyroid disorder treatment.

Nutritional Profile

Goat thyroid extract (desiccated) is a protein-dominant glandular product with composition extrapolated from mammalian thyroid gland physiology. Protein content is estimated at 60-70% of dry weight, comprising thyroglobulin (the primary storage glycoprotein, ~660 kDa homodimer), thyroperoxidase, and structural proteins. Active thyroid hormones present include thyroxine (T4) and triiodothyronine (T3) in an approximate ratio of 4:1 (T4:T3), consistent with other desiccated thyroid extracts (e.g., porcine DTE contains ~38 mcg T4 and ~9 mcg T3 per grain/65 mg). Goat-specific hormone concentrations are uncharacterized in published literature but are presumed within a similar range given conserved thyroid physiology across mammals. Iodine content is significant, estimated at 0.5-1.0% of dry weight, as iodine is covalently bound within thyroglobulin residues (monoiodotyrosine, diiodotyrosine). Calcitonin may be present as a minor bioactive peptide from parafollicular C-cells. Micronutrient trace residuals include selenium (integral to deiodinase enzymes in thyroid tissue, ~0.1-0.3 mcg/g dry weight estimated), zinc, and iron from vascular components. Fat content is low (<5% dry weight), primarily structural phospholipids. Carbohydrate content is minimal (<3%), mainly glycosaminoglycan residues from thyroglobulin glycosylation. Bioavailability of T3 is high (~95% oral absorption); T4 oral bioavailability is approximately 70-80%, both subject to interference by calcium, iron, and food. No goat-specific nutritional assay data is published; all quantitative values are inferred from porcine/bovine DTE literature and general mammalian thyroid biochemistry.

Preparation & Dosage

No clinically studied dosages exist for goat thyroid extract in humans. Porcine DTE studies used stable levothyroxine-equivalent doses without specified mg ranges. No standardization data (T4:T3 ratios) available for goat-derived products. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Selenium, Iodine, Zinc, Vitamin D, Ashwagandha

Safety & Interactions

Because goat thyroid extract contains active thyroid hormones T3 and T4, it carries real risks of thyrotoxicosis, including palpitations, tachycardia, anxiety, insomnia, tremor, and bone density loss with excessive or prolonged use. It can significantly interact with levothyroxine and other thyroid medications, causing additive hyperthyroid effects, and may reduce the efficacy of anticoagulants such as warfarin by accelerating clotting factor metabolism. It is contraindicated in individuals with hyperthyroidism, adrenal insufficiency, and cardiovascular disease, and should not be used during pregnancy or breastfeeding without explicit endocrinologist supervision due to risks of fetal thyroid disruption. Individuals taking antidiabetic medications, SSRIs, or cholestyramine should exercise particular caution, as thyroid hormone levels interact with insulin sensitivity and drug absorption.